X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (49057) 49057
Book Review (9718) 9718
Publication (3456) 3456
Conference Proceeding (179) 179
Magazine Article (178) 178
Book Chapter (126) 126
Book / eBook (102) 102
Dissertation (29) 29
Newsletter (29) 29
Newspaper Article (9) 9
Web Resource (8) 8
Paper (5) 5
Trade Publication Article (5) 5
Data Set (4) 4
Presentation (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (46728) 46728
humans (41161) 41161
male (29945) 29945
female (26264) 26264
middle aged (19519) 19519
diabetes mellitus, type 2 - physiopathology (17652) 17652
diabetes (17205) 17205
endocrinology & metabolism (15540) 15540
adult (15254) 15254
animals (12811) 12811
aged (12508) 12508
risk factors (10512) 10512
type 2 diabetes (7808) 7808
diabetes mellitus, type 1 - physiopathology (7627) 7627
diabetes mellitus (7203) 7203
diabetes mellitus, type 2 - complications (6811) 6811
mellitus (6504) 6504
insulin resistance (6257) 6257
blood glucose - metabolism (6247) 6247
rats (6087) 6087
obesity (5485) 5485
insulin (5355) 5355
abridged index medicus (5321) 5321
glucose (5094) 5094
blood pressure (4940) 4940
hypertension (4899) 4899
diabetes mellitus, type 2 - blood (4805) 4805
research (4786) 4786
diabetes mellitus - physiopathology (4688) 4688
body mass index (4181) 4181
analysis (4143) 4143
diabetes mellitus, type 2 - drug therapy (4115) 4115
mice (4047) 4047
diabetes mellitus, experimental - physiopathology (4025) 4025
adolescent (4003) 4003
prevalence (3944) 3944
care and treatment (3851) 3851
insulin-resistance (3804) 3804
medicine & public health (3763) 3763
risk (3738) 3738
time factors (3738) 3738
health aspects (3567) 3567
mortality (3501) 3501
obesity - physiopathology (3473) 3473
physiological aspects (3438) 3438
internal medicine (3250) 3250
cardiac & cardiovascular systems (3224) 3224
disease (3224) 3224
oxidative stress (3185) 3185
hypoglycemic agents - therapeutic use (3116) 3116
insulin - blood (3085) 3085
diabetes-mellitus (3052) 3052
cross-sectional studies (2955) 2955
metabolic syndrome (2902) 2902
hyperglycemia (2874) 2874
follow-up studies (2847) 2847
diabetics (2832) 2832
hypertension - physiopathology (2797) 2797
diabetes mellitus, type 2 - metabolism (2789) 2789
blood glucose - analysis (2787) 2787
prospective studies (2751) 2751
insulin - metabolism (2737) 2737
treatment outcome (2721) 2721
diabetic nephropathies - physiopathology (2701) 2701
diabetes mellitus, type 1 - complications (2676) 2676
aged, 80 and over (2668) 2668
complications (2660) 2660
cardiovascular disease (2655) 2655
peripheral vascular disease (2579) 2579
type 1 diabetes (2570) 2570
medicine, general & internal (2545) 2545
medicine (2492) 2492
case-control studies (2459) 2459
risk-factors (2431) 2431
pharmacology & pharmacy (2423) 2423
physiology (2403) 2403
child (2377) 2377
diabetes mellitus, type 2 - epidemiology (2348) 2348
metabolism (2347) 2347
diabetic neuropathies - physiopathology (2336) 2336
cardiovascular-disease (2333) 2333
studies (2308) 2308
glycated hemoglobin a - analysis (2305) 2305
atherosclerosis (2266) 2266
insulin resistance - physiology (2255) 2255
disease models, animal (2211) 2211
reference values (2198) 2198
biomarkers - blood (2172) 2172
diabetic angiopathies - physiopathology (2171) 2171
inflammation (2126) 2126
pregnancy (2119) 2119
research article (2116) 2116
disease progression (2100) 2100
glucose tolerance test (2098) 2098
exercise (2082) 2082
dextrose (2074) 2074
article (2051) 2051
medicine, research & experimental (2034) 2034
young adult (2032) 2032
diagnosis (2028) 2028
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (68) 68
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
Online Resources - Online (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Not Returned (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (47113) 47113
French (438) 438
Russian (383) 383
German (296) 296
Chinese (218) 218
Japanese (213) 213
Spanish (188) 188
Polish (155) 155
Italian (74) 74
Portuguese (63) 63
Czech (62) 62
Hungarian (35) 35
Slovak (27) 27
Danish (23) 23
Dutch (20) 20
Hebrew (17) 17
Romanian (17) 17
Serbian (16) 16
Ukrainian (15) 15
Swedish (13) 13
Croatian (10) 10
Finnish (9) 9
Turkish (8) 8
Korean (6) 6
Bulgarian (5) 5
Norwegian (3) 3
Icelandic (2) 2
Arabic (1) 1
Bosnian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, ISBN 9780849323072, 476
Book
Diabetes Care, ISSN 0149-5992, 12/2010, Volume 33, Issue 12, pp. e147 - e167
Although physical activity (PA) is a key element in the prevention and management of type 2 diabetes, many with this chronic disease do not become or remain... 
Diabetes Mellitus, Type 2 - diagnosis | Exercise - physiology | Diabetes Mellitus, Type 2 - physiopathology | Humans | Diabetes Mellitus, Type 2 - prevention & control | Index Medicus | Position Statement
Journal Article
Circulation, ISSN 0009-7322, 01/2018, Volume 137, Issue 2, pp. 119 - 129
BACKGROUND:Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced cardiovascular morbidity and mortality in patients with type 2 diabetes mellitus... 
Treatment outcome | Hospitalization | Kidney diseases | Mortality | Diabetes mellitus type 2 | Sodiumglucose transporter 2 | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | hospitalization | SAFETY | HEART-FAILURE | sodium-glucose transporter 2 | RISK | DEATH | MECHANISMS | treatment outcome | IMPACT | kidney diseases | mortality | PERIPHERAL VASCULAR DISEASE | diabetes mellitus, type 2 | SGLT2 INHIBITION | PROGRESSION | Prevalence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Cause of Death | Renal Insufficiency, Chronic - drug therapy | Albuminuria - physiopathology | Glomerular Filtration Rate - drug effects | Benzhydryl Compounds - adverse effects | Albuminuria - mortality | Time Factors | Cardiovascular Diseases - mortality | Renal Insufficiency, Chronic - mortality | Female | Glucosides - therapeutic use | Renal Insufficiency, Chronic - diagnosis | Benzhydryl Compounds - therapeutic use | Glucosides - adverse effects | Kidney - physiopathology | Cardiovascular Diseases - diagnosis | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Cardiovascular Diseases - physiopathology | Kidney - drug effects | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Risk Factors | Treatment Outcome | Renal Insufficiency, Chronic - physiopathology | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - physiopathology | Diabetes Mellitus, Type 2 - mortality | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Care and treatment | Index Medicus | Abridged Index Medicus
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 02/2015, Volume 35, Issue 4, pp. 1022 - 1029
Objectives-The first objective of this study was to demonstrate differences within endothelial-dependent and endothelial-independent vasoreactivity in... 
endothelial function | metabolic syndrome | macrocirculation | microcirculation | smooth muscle function | MICROVASCULAR DYSFUNCTION | REACTIVITY | BLOOD-PRESSURE | EXERCISE | HYPEREMIA | BRACHIAL-ARTERY | FLOW-MEDIATED VASODILATION | INSULIN-RESISTANCE | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Predictive Value of Tests | Muscle, Smooth, Vascular - metabolism | Humans | Middle Aged | Obesity, Abdominal - diagnosis | Obesity, Abdominal - physiopathology | Male | Insulin - blood | Microcirculation - drug effects | Muscle, Smooth, Vascular - physiopathology | Inflammation - blood | Iontophoresis | Metabolic Syndrome - blood | Diabetic Angiopathies - physiopathology | Adiposity | Metabolic Syndrome - physiopathology | Inflammation - diagnosis | Prediabetic State - blood | Blood Glucose - analysis | Cross-Sectional Studies | Risk Reduction Behavior | Risk Factors | Endothelium, Vascular - physiopathology | Inflammation Mediators - blood | Biomarkers - blood | Diabetic Angiopathies - blood | Regional Blood Flow | Prediabetic State - diagnosis | Skin - blood supply | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Prediabetic State - physiopathology | Endothelium, Vascular - metabolism | Metabolic Syndrome - diagnosis | Blood Flow Velocity | Diabetic Angiopathies - diagnosis | Aged | Vasodilation - drug effects | Nitric Oxide - metabolism | Vasodilator Agents - administration & dosage | Inflammation - physiopathology | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 09/2013, Volume 128, Issue 12, pp. 1325 - 1334
Journal Article
Diabetes Care, ISSN 0149-5992, 08/2016, Volume 39, Issue Supplement 2, pp. S165 - S171
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease worldwide. Blood glucose and blood pressure control reduce the risk of developing... 
GLUCOSE COTRANSPORTER 2 | DAPAGLIFLOZIN | CANAGLIFLOZIN | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | RENAL-DISEASE | GLOMERULAR HYPERFILTRATION | TYPE-2 | NEPHROPATHY | BLOOD-PRESSURE | EMPAGLIFLOZIN | Albuminuria - complications | Cardiovascular Diseases - prevention & control | Humans | Kidney Glomerulus - physiopathology | Diabetes Mellitus, Type 1 - complications | Glomerular Filtration Rate - physiology | Albuminuria - physiopathology | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Glucosides - therapeutic use | Blood Pressure - drug effects | Blood Pressure - physiology | Benzhydryl Compounds - therapeutic use | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Hypoglycemic Agents - therapeutic use | Kidney Failure, Chronic - physiopathology | Kidney - drug effects | Cardiovascular Diseases - metabolism | Diabetes Mellitus, Type 1 - physiopathology | Kidney Failure, Chronic - drug therapy | Kidney Glomerulus - drug effects | Risk Factors | Sodium-Glucose Transporter 2 Inhibitors | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - physiopathology | Albuminuria - drug therapy | Diabetes Mellitus, Type 1 - blood | Kidney Failure, Chronic - complications | Renin-Angiotensin System - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 07/2007, Volume 116, Issue 2, pp. 163 - 173
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 7, pp. 644 - 657
In this report of two randomized trials, patients with type 2 diabetes at risk for cardiovascular disease received the sodium–glucose cotransporter 2 inhibitor... 
MEDICINE, GENERAL & INTERNAL | METAANALYSIS | ATRIAL-NATRIURETIC-PEPTIDE | RATIONALE | INTENSIVE GLUCOSE CONTROL | PLACEBO-CONTROLLED TRIAL | OUTCOMES | INHIBITORS | STAGE KIDNEY-DISEASE | PROGRESSION | BASE-LINE CHARACTERISTICS | Hypoglycemic Agents - therapeutic use | Albuminuria - complications | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Kidney Diseases - mortality | Male | Canagliflozin - adverse effects | Disease Progression | Foot - surgery | Glomerular Filtration Rate - drug effects | Diabetes Mellitus, Type 2 - physiopathology | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Aged | Amputation - statistics & numerical data | Kidney Diseases - etiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Heart | Complications and side effects | Care and treatment | Abnormalities | Amputation | Myocardial infarction | Heart attacks | Body weight | Clinical trials | Cardiovascular disease | Blood pressure | Drug dosages | Heart failure | Cerebral infarction | Stroke | Statistical analysis | Kidneys | Metatarsal | Diabetes mellitus | Toe | FDA approval | Glomerular filtration rate | Medicine | Studies | Side effects | Sodium | Diabetes | Kidney diseases | Cardiovascular diseases | Health risk assessment | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article